Avammune Therapeutics
PrivateLast Round
Series A
May 7, 2025
Total Funding Raised
$24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avammune Therapeutics is a biopharmaceutical company developing a pipeline of small-molecule drugs designed to modulate the innate immune system for treating cancer and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avammune Therapeutics Comparables
Compare Avammune Therapeutics with similar companies based on industry and business-model similarity.
Avammune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 7, 2025 | ||||
| Series A | May 7, 2024 | ||||
| Angel | Jul 15, 2022 | ||||
| Seed | Jul 9, 2019 |
Avammune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Chennai Angels | Angel |
| Shastra VC | Series A |
| 1Crowd | Series A |
| Capital 2B | Series A |
| IvyCap Ventures | Series A |
| Kotak Alternate Asset Managers | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Grew 21% QoQ, from 14 to 17 employees.
- Apr 26, 2026
Grew 45% QoQ from 11 to 16 employees.
Avammune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avammune Therapeutics's valuation, stock price, and market status.